Tempus Labs is a healthcare data analytics platform operator that aims to actualize precision medicine by integrating artificial intelligence into healthcare. The company's extensive library of molecular and clinical data, coupled with its operating system, offers genomic sequencing services. It also analyzes molecular and therapeutic data, equipping users with the ability to make immediate, data-informed decisions. This advanced technology from Tempus Labs allows physicians to provide customized care for patients using an interactive analytical and machine-learning platform.

Investors include:

Further Key Investors:

Baillie Gifford, Revolution Group, Novo Holdings, Lightbank, Kinship Trust Company, T. Rowe Price, Revolution (Washington DC), Alphabet, Kilmahew Ventures, Franklin Templeton, Franklin Venture Partners, Illinois Growth and Innovation Fund.

Own Tempus Labs stock or options?

Get an instant valuation

Completely free
100% confidential & secure
Takes less than a minute

What company do you own stock or options in?

How many shares or options do you own?

100% private & secure